Antibody-Drug Conjugates

56 Employers in 289 locations

Antibody-Drug Conjugates (ADCs) are made by using a linker to join an antibody with some kind of chemical. These drugs benefit from the specificity of monoclonal antibodies and the toxicity of the chemical. As a consequence the treatment is less harmful to patients since it can kill the problem cells (usually cancer) without harming normal cells.

 

Employers working on Antibody-Drug Conjugates work in 58 other areas

Displaying 1 - 15 of 58 related areas

Locale
Careers
Internships

Displaying 1 - 56 of 56 employers

Only three business areas are listed for each employer.

Business Area(s)
Description
Abbvie produces monoclonal antibody drugs such as Humira and Skyrizi, in ...

Description
A bio-conjugate contract research organization.

Description
ADC Therapeutics is developing antibody drug conjugates (ADCs) with highly ...

Description
Adcytherix is a biopharmaceutical company focused on the development of novel ...

Description
Alteogen is making biosimilars to target Her2 and treat cancer.

Description
Ambrx uses Protein Medicinal Chemistry™ to modify proteins or antibodies to ...

Description
A biopharmaceutical company that focuses on Cardiovascular and Metabolic ...

Description
Specializes in API small molecule and ADC production.

Description
Bicycles are a new therapeutic modality combining the attributes of antibodies ...

Description
BioAtla ® has patented a platform for developing conditionally active ...

Description
BioDlink (formerly known as TOT BIOPHARM International Company Limited) is a ...

Business Area(s)
Description
Bolt Biotherapeutics develops the Boltbody™ platform, which consists of ...

Description
Use protein engineering capabilities to create the next-generation of ...

Description
A biopharmaceutical company. They discover, develop, and deliver medicines to ...

Description
Byondis is a biopharmaceutical company developing precision medicines that ...

Description
Developing next-generation, multi-payload antibody-drug conjugates (ADCs) that ...

Description
a cancer therapeutics company

Description
Develops cancer immunotherapies, drug conjugates (PDCs), T-cell engaging Probody ...

Description
Daiichi Sankyo Cancer is a global pharmaceutical company that makes treatments ...

Description
Contract Development & Manufacturing. The company is partnering with Takeda to ...

Description
DualityBio is a clinical stage company focusing on the discovery and development ...

Description
Eisai Inc. (pronounced ā-zī) is a U.S. pharmaceutical subsidiary of Tokyo-based ...

Description
Small Molecules

Description
Large pharma in Shanghai - Its Fosun Long March Medical Science subsidiary has a ...

Description
GlaxoSmithKline is a science-led global healthcare company with 3 global ...

Description
Heidelberg Pharma AG based in Ladenburg, Germany, is a biopharmaceutical company ...

Description
Immunome is a clinical stage company developing targeted therapies designed to ...

Description
Innate Pharma is a global clinical-stage oncology-focused biotech company. Their ...

Business Area(s)
Description
Kelun-Biotech (holding subsidiary of Sichuan Kelun Pharmaceutical) is a clinical ...

Description
KLUS Pharma uses antibody discovery and engineering to discover targets and ...

Description
LigaChemBio Biosciences, Inc. (LCB) is a researched-based biotechnology company ...

Business Area(s)
Description
A clinical-stage biopharmaceutical company focused on discovering and developing ...

Description
Small Molecules and therapeutics. Merck Exploratory Science Center (Merck ESC) ...

Description
Small Molecules, Purification Equipment, etc. Merck KGaA is collaborating with ...

Description
Drug Delivery

Description
Molecular Templates (MTEM) is a clinical stage biopharmaceutical company ...

Description
The company is developing ADC product candidates to create better treatments for ...

Description
Small Molecules, Vaccines, Biologics, Novartis Gene Therapies develops and ...

Description
Biologics

Business Area(s)
Description
A clinical-stage biotech company pioneering Tumor Quantum Immunotherapy to ...

Description
Oqory is a clinical-stage company developing advanced antibody-drug conjugates ...

Description
Antibody Therapies

Description
Biologics, Pfizer plans to screen potential compounds for activity against COVID ...

Description
Pyxis Oncology has assembled a differentiated portfolio of potent biologics ...

Business Area(s)
Description
Developing antibody-drug conjugates against receptor tyrosine kinase-like orphan ...

Description
Rakuten Aspyrian is a privately funded clinical stage biotechnology company ...

Description
Develop antibodies and fusion proteins, antibody-drug conjugates (ADCs), and ...

Business Area(s)
Description
Biologics. China is recommending that doctors use a Roche product, Actemra, to ...

Description
RoukenBio is a specialist immunology Contract Research Organisation (CRO) that ...

Business Area(s)
Description
Sanofi provides healthcare solutions in 170 countries and has 69 manufacturing ...

Description
Developing novel immunotherapies against medically-relevant targets utilizing ...

Description
Biochemical Protein Synthesis Platform

Description
Systimmune Inc. is a bio-pharmaceutical company focused on the treatment of ...

Description
Vector Laboratories is a global manufacturer of life science reagents, labeling ...

Description
Xcellon Biologics, LLC is a Contract Development and Manufacturing Organization ...

Description
Zymeworks designs innovative biologics platforms to engage novel disease ...